Share of clinical development medicines dedicated to non-communicable diseases
RecordSTO-01M2KJ7XCG-3Y4BJ2059J-BJMGF1
Global · 2025
Share of clinical development medicines dedicated to non-communicable diseases worldwide was 75% in 2025 (IFPMA).
Share of clinical development medicines dedicated to non-communicable diseases: every country and year, and how it is measured
- Publisher
- IFPMA
- Authority tier
- T2 Official
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).
Checked: the figure 75%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1
Other formats: MLA, Chicago, BibTeX
- MLA
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
- Chicago
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
- BibTeX
- @misc{ifpma2025sharebjmgf1, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IFPMA · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Type
- Press release
- Published
- —
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Permanent URL
- /stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1